Vertex Pharmaceuticals Inc
1 member of Congress bought
Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-08-26 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $1,001 - $15,000 |
| 2026-01-29 | David J. Taylor · R-OH | House | Sold | $1,001 - $15,000 |
| 2025-08-07 | David J. Taylor · R-OH | House | Bought | $1,001 - $15,000 |
| 2025-06-11 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-06-10 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve · R-IN | House | Sold | $15,001 - $50,000 |
| 2025-03-20 | Byron Donalds · R-FL | House | Sold | $1,001 - $15,000 |
| 2025-03-13 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
| 2025-02-24 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
Show the other 13
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2024-12-11 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2024-05-03 | Tommy Tuberville · R-AL | Senate | Sold | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton · D-AZ | House | Sold | $1,001 - $15,000 |
| 2022-03-29 | William R. Keating · D-MA | House | Bought | $1,001 - $15,000 |
| 2021-01-28 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2020-12-18 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | Sold | $1,001 - $15,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
| 2019-04-18 | Donna E. Shalala · D-FL | House | Bought | $1,001 - $15,000 |
| 2019-02-04 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2018-03-09 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2015-05-13 | Jack Reed · D-RI | Senate | Sold | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-11-06 | Kewalramani Reshma | Insider | SELL | 11,866 | $531.53 | $6,307,135 |